A cannula is a tube that can be inserted into the body, often for the delivery or removal of fluid or for the gathering of data.
Traditionally, dermal fillers have been injected using needles. In fact, most dermal fillers are still packaged with two short (1/2 inch) needles as the recommended means of injecting the product. However, there are several advantages of not using the supplied needle, and instead, using a blunt tipped cannula for the injection of dermal fillers.
When using a needle, the sharp tip of the needle penetrates through the skin and down to the depth where the filler is injected. In contrast to this, a cannula has a blunt tip, and therefore cannot pierce the skin. A needle is required to make an entry point for the cannula that just passes through the skin. The cannula is then used to pass through the entry point to the areas beneath the skin. The blunt tipped cannula can re-enter the same entry point again without having to hurt the patient with another needle puncture.
Because the cannula is blunt, it is not as indiscriminate as a needle as it passes through the tissues. Needles, being sharp tipped, may more easily pass into or through a vein or artery. This can cause significant bruising or swelling, and at worst, intravascular injection (injection of filler into the artery or vein, which can cause serious complications). Cannulae (plural for cannula), being blunt, are less likely to pass into a vein or artery, and therefore cause less bruising or swelling and tend to avoid intravascular injection. Instead, the blunt tip tends to push veins or arteries aside as they are passed through the tissues. Furthermore, the practitioner is able to feel resistance from structures that a cannula pass through, allowing them to judge when and how to apply pressure or manipulate the direction of the cannula. Finally, cannulae tend to be longer than most needles and therefore reach more areas with fewer entry points into the skin.
This report elaborates the market size, market characteristics, and market growth of the Dermal Filler Cannula industry, and breaks down according to the type, application, and consumption area of Dermal Filler Cannula. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Dermal Filler Cannula in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Dermal Filler Cannula market covered in Chapter 13:
In Chapter 6, on the basis of types, the Dermal Filler Cannula market from 2015 to 2025 is primarily split into:
In Chapter 7, on the basis of applications, the Dermal Filler Cannula market from 2015 to 2025 covers:
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
Europe (Covered in Chapter 9)
Asia-Pacific (Covered in Chapter 10)
Middle East and Africa (Covered in Chapter 11)
South America (Covered in Chapter 12)
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025